David McNabb, of biological sciences, named acting associate dean of Fulbright College

Photo submitted

David McNabb

David McNabb has been named acting associate dean of the Fulbright College of Arts and Sciences, having served as chair of the college’s biological sciences department since 2017 and vice chair since 2012.

McNabb has also been a faculty member at the U of A for more than 22 years.

“David brings such a wealth of research expertise, academic leadership, teaching and mentoring talents to this role, as well as his ongoing, regular and measured approach to fostering student, faculty and staff success during this vital time for the college,” said Kathryn Sloan. , acting dean of Fulbright College.

“We are delighted to have him join our team in the Fulbright College Dean’s Office as Acting Associate Dean, and we are delighted to work with him in this new role,” she added.

As Acting Associate Dean, McNabb will serve as the administrative liaison between the Fulbright College Dean’s Office and several areas, services, departments and centers, including English, the Institute for Integrative and Innovative Research (I3R), the Curriculum premedical, Museum University, and STEM-E, as well as administrative areas of the college, including Workday, faculty travel, facilities management, sponsored programs, Streamlyne, and all college research centers and grants.

“My career has always been about helping people, whether through my research and teaching or through my time as an academic leader,” McNabb said. “As Associate Dean, I hope to continue to help our college’s faculty, staff, and students excel and provide them with the opportunities, tools, and equipment they need to do so.”

“I am honored by this opportunity to continue serving, excited to work more closely with our Dean’s Office team in this new role, and look forward to another great academic year at Fulbright College,” he said. -he declares.

McNabb’s research interests center on the development and identification of antifungal compounds or peptides for potential use in the treatment of fungal infections in humans, the role of CCAAT binding factor in Candida albicans the pathogenesis and application of solid state nanopores as single molecule sensors for applications in biological systems.

Additionally, McNabb has received millions of dollars in research funding from organizations including the National Institutes of Health, National Science Foundation, Howard Hughes Medical Institute, Arkansas Biosciences Institute, American Heart Association, US Food and Drug Administration and more.

He also holds four US patents for his collaborative research, has authored or co-authored dozens of articles in leading journals, including PLoS One, Advances in biotechnology, Nanotechnology and more and has presented his research at dozens of conferences around the world.

McNabb serves as an ad hoc reviewer for several scientific journals and textbooks in cell and molecular biology, and currently serves at the U of A on its academic toxic substances committees, the Communicable Disease Outbreak Committee, and the Committees of university building facilities.

He is also a member of the Council on Genomics and Precision Medicine of the American Heart Association, the Biological Chemistry Division of the American Chemical Society, Sigma Xi, the Genetics Society of America, and the American Society for Microbiology.

In addition to his extensive research background, McNabb has been widely recognized by the U of A and Fulbright College for his dedication to students and excellence in teaching, winning the U of A’s Outstanding Mentor Award. 14 times over the past 20 years, as well as being an inductee as a U of A Teaching Fellow and a past recipient of the college’s Master Teacher Award.

McNabb holds a BS in microbiology from the University of Texas at Arlington and a Ph.D. in Biochemistry and Molecular Biology from Louisiana State University Medical Center.

Comments are closed.